Inactive Instrument
Sector Aviragen Therapeutics Inc Nasdaq
Stocks
US0906941002
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-08 | Vaxart, Inc., Q2 2026 Earnings Call, Aug 07, 2026 | |
| 08-07 | Vaxart, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.07% | +13.76% | +35.00% | +49.04% | +79.09% | +65.44% | +106.53% | +17.00% | - | 71.56B | |
| -1.30% | -2.44% | -2.18% | +7.26% | +3.88% | +33.78% | +62.90% | +185.18% | +5,307.41% | 54.43B | |
| -4.50% | -4.69% | +15.75% | +7.07% | -27.41% | +2.82% | +463.22% | +436.21% | +960.71% | 27.59B | |
| -1.66% | -1.96% | +17.70% | +37.75% | +43.00% | +45.88% | +5.66% | -62.84% | - | 23.91B | |
| -0.67% | +1.02% | +2.28% | -0.12% | -3.24% | -18.32% | -13.84% | -75.59% | - | 23.14B | |
| +0.64% | +1.90% | +9.52% | +20.50% | +0.49% | +39.66% | -19.64% | -30.41% | +79.79% | 18.65B | |
| +0.35% | +12.02% | +15.60% | +104.98% | +241.04% | +257.19% | +466.50% | +1,776.37% | +864.12% | 18.64B | |
| -1.05% | -3.71% | +4.28% | +19.48% | +32.46% | +19.81% | +611.64% | - | - | 16.01B | |
| +0.46% | -3.05% | -9.69% | -1.33% | +15.47% | +31.49% | +135.18% | +176.86% | +374.77% | 12.54B | |
| -5.38% | -0.59% | -4.45% | -2.22% | -12.87% | +35.86% | +195.96% | +497.89% | +6,637.98% | 11.72B | |
| -1.90% | -0.28% | +15.49% | +9.90% | +28.92% | +328.16% | +196.67% | +41.42% | +1,336.07% | 12.09B | |
| -7.28% | +3.40% | -8.50% | -25.49% | -19.95% | -47.90% | +713.95% | +76.77% | +110.18% | 11.17B | |
| -6.95% | -3.60% | +0.57% | -22.13% | -14.69% | -41.29% | +186.90% | +120.85% | - | 12.16B | |
| -2.90% | -9.73% | -10.69% | -4.88% | +15.60% | +99.16% | +124.27% | +128.46% | +504.53% | 10.21B | |
| -2.15% | -1.52% | +8.66% | +33.47% | +210.90% | +485.34% | +714.80% | -32.44% | -11.44% | 8.98B | |
| -1.88% | -6.14% | -1.88% | -10.01% | +12.43% | +4.52% | +120.87% | -22.54% | - | 9.1B | |
| -0.02% | +0.62% | +0.92% | +125.29% | +81.40% | +180.62% | +411.29% | +279.34% | - | 8.96B | |
| -1.32% | -0.05% | +3.21% | +8.50% | +27.57% | +86.56% | +24.68% | +126.12% | - | 8.76B | |
| -1.16% | +4.51% | -1.80% | -6.13% | +286.36% | +171.28% | +318.03% | -32.00% | - | 8.11B | |
| Average | -1.93% | +2.34% | +4.73% | +18.47% | +52.65% | +93.69% | +253.98% | +200.37% | +1,616.41% | 19.35B | |
| Weighted average by Cap. | -1.18% | +2.87% | +10.15% | +23.06% | +44.98% | +70.83% | +200.27% | +192.41% | +2,354.10% |
- Stock Market
- Stocks
- VXRT Stock
- Stock
- Sector Aviragen Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
